Trulicity ® (dulaglutide)

This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information.For current prescribing information for all Lilly products, including Summaries of Product Characteristics, Patient Information Leaflets and Instructions for Use, please visit: www.medicines.org.uk (England, Scotland, Wales) or www.emcmedicines.com/en-GB/northernireland/ (Northern Ireland).

Can Trulicity® (dulaglutide) be prescribed in patients with cancer?

Eli Lilly and Company does not have information on the use of dulagutide in patients with cancer.

UK_cFAQ_GLP029_CANCER
UK_cFAQ_GLP029_CANCER
en-GB

Why is no information available?

Dulaglutide has not been studied in patients with cancer and we therefore have no information on its use in this patient population.

Date of Last Review: 03 November 2020


Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com

Available Mon - Fri, 10am - 4pm, excluding Bank Holidays

Or you can

Chat with Us

Click to Chat is Offline

If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a request